Please login to the form below

Not currently logged in
Email:
Password:

Transforming Access to Medicines Through Patient-Centric Solutions

As medicines access evolves and pharmaceutical companies take an increasingly nuanced approach to it, it’s ever-more important to focus on particular aspects of this area and investigate whether firms are operating optimally.

To do this Inceptua Medicines Access and patient group, HAEi, in association with PMGroup, will host a free webinar on Thursday 14th December that will cover both the pre-approval access to medicines and the importance of putting patients at the heart of drug development and access.

Pre-approval access - a transformational approach

There are a number of factors at play within the world of medicines access: from industry who need to navigate requests for their pre-approval and unlicensed medicines, to healthcare professionals who are looking for options for their patients and ultimately to the patients and patient advocacy groups who are more empowered than ever and are driving for more timely access to treatments. Today’s healthcare, political and regulatory environments burden have generated a rapid, increasing and significant expansion in the need for access to these medicines. Mark Corbett, Executive Vice President at Inceptua Medicines Access talks about the company’s transformative approach to medicines access, designed to rise to the evolving challenges of the environment, offering unsurpassed understanding and insight into the needs of biopharmaceutical companies and healthcare organisations.

Patients at the heart of drug development and access

If you believe the news every day, patients are becoming more and more involved in drug development and access pathways, but what does this mean in reality? Hear from Henrik Balle Boysen, Executive Director of the patient organisation HAEi on how the organisation is taking innovative approaches to ensuring patients play a central role in tackling rare diseases leading to improvements in clinical trial recruitment, appropriate access to pre-approval medicines and collaborations that benefit all stakeholders to overcome some of the obvious challenges that exist in these therapy areas.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
wethepeople

wethepeople are bringing human appeal back to brand communications. Our approach allows us to create strategies, ideas and experiences that...

Latest intelligence

Report: Achieving launch excellence in the challenging healthcare markets of today
Our in-depth report is based on original data and expert interviews, which coupled with our own experience, ensures we give you the best recommendations for achieving launch success in challenging...
What is blockchain and why should i care - Richard Springham
Four Health - Emerging Technologies The power of blockchain lies in the fact it can prove that a unique event occurred at a certain time with out the need to...
NHS medicines optimisation milestone
Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare Consulting Team, explore the implications of Adalimumab’s recent European patent expiry...

Infographics